Patents-Review.com
🔗 Permalink
Assignee profile:

Laboratoire HRA-PHARMA

City:

Paris

Country:

France

Published Applications:

23

Last publication date:

2019-07-11

Patent Grants:

19

Last grant date:

2020-09-15

Top Inventors for applications by Laboratoire HRA-PHARMA

These are the the leading inventors for applications assigned to Laboratoire HRA-PHARMA:

Recent patent applications by Laboratoire HRA-PHARMA

Laboratoire HRA-PHARMA based in Paris, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2019-07-11 ✅ Patent 10,772,897 granted on 2020-09-15
US20190209583A1
Human necessities

Method for on-demand contraception

 #2 | 2017-03-02 ✅ Patent 9,855,282 granted on 2018-01-02
US20170056417A1
Human necessities

Method for scheduling ovulation

 #3 | 2017-01-19 ✅ Patent 9,814,732 granted on 2017-11-14
US20170014426A1
Human necessities

Ulipristal acetate for prevention and treatment of breast tumors

 #4 | 2016-11-03 ✅ Patent 10,159,681 granted on 2018-12-25
US20160317555A1
Human necessities

Method for on-demand contraception

 #5 | 2016-10-06 ✅ Patent 9,844,510 granted on 2017-12-19
US20160287518A1
Human necessities

Ulipristal acetate tablets

 #6 | 2016-01-28 ✅ Patent 9,682,088 granted on 2017-06-20
US20160022698A1
Human necessities

Method for treating uterine fibroids

 #7 | 2016-01-28 ✅ Patent 9,522,154 granted on 2016-12-20
US20160022697A1
Human necessities

Method for scheduling ovulation

 #8 | 2015-10-15 ✅ Patent 9,610,293 granted on 2017-04-04
US20150290218A1
Human necessities

Co-micronization product comprising ulipristal acetate

 #9 | 2015-06-25 ✅ Patent 9,283,233 granted on 2016-03-15
US20150174140A1
Human necessities

Method for on-demand contraception

 #10 | 2014-08-21
US20140235603A1
Human necessities

METHODS, DOSING REGIMENS AND MEDICATIONS USING ANTI-PROGESTATIONAL AGENTS FOR THE TREATMENT OF DISORDERS

 #11 | 2014-08-14
US20140228335A1
Human necessities

Ulipristal Acetate Tablets

 #12 | 2014-07-03 ✅ Patent 9,180,133 granted on 2015-11-10
US20140187525A1
Human necessities

Method for treating uterine fibroids

 #13 | 2013-08-15 ✅ Patent 8,962,603 granted on 2015-02-24
US20130210788A1
Human necessities

Method for post coital contraception in overweight or obese female subjects using ulipristal acetate

 #14 | 2013-04-11
US20130090318A1
Human necessities

ONCE-A-MONTH METHOD OF CONTRACEPTION

 #15 | 2013-01-24 ✅ Patent 8,722,653 granted on 2014-05-13
US20130023506A1
Human necessities

Method for treating uterine fibroids

 #16 | 2012-05-17 ✅ Patent 9,616,073 granted on 2017-04-11
US20120122828A1
Human necessities

Method for on-demand contraception

 #17 | 2012-05-10
US20120115802A1
Human necessities

Method for using ulipristal acetate with cytochrome isozyme modulators

 #18 | 2012-03-29 ✅ Patent 8,735,380 granted on 2014-05-27
US20120077790A1
Human necessities

Ulipristal acetate tablets

 #19 | 2011-10-06 ✅ Patent 9,180,131 granted on 2015-11-10
US20110245211A1
Human necessities

Method for contraception

 #20 | 2011-06-09 ✅ Patent 8,426,392 granted on 2013-04-23
US20110136770A1
Human necessities

Method for providing emergency contraception

 #21 | 2010-06-10 ✅ Patent 8,512,745 granted on 2013-08-20
US20100144692A1
Human necessities

Ulipristal acetate tablets

 #22 | 2009-07-30 ✅ Patent 8,299,050 granted on 2012-10-30
US20090192130A1
Human necessities

Method for treating uterine fibroids

 #23 | 2008-08-21 ✅ Patent 8,865,200 granted on 2014-10-21
US20080199511A1
Human necessities

Sustained release compositions containing progesterone receptor modulators

Also check out Laboratoire HRA-PHARMA's (Paris, France) applicant profile with 11 patent applications submitted.

AssigneeID:

6097 ⎘